UW Antiphospholipid + SLE 02-17 (1) Flashcards
UW. Antiphospholipid. table. clinical. vascular thrombosis?
Arterial or venous
UW. Antiphospholipid. table. clinical. pregnancy morbidity? 3
> = 3 consecutive, unexplained fetal losses before 10th week
> = 1 unexplained fetal losses after 10 week
> =1 premature births of normal neonates before 35th week due to preeclampsia, eclampsia, or placental insufficienty
UW. Antiphospholipid. table. clinical. pregnancy morbidity.
…
> = 1 unexplained fetal losses after 10 week
> =1 premature births of normal neonates before 35th week due to preeclampsia, eclampsia, or placental insufficienty
> = 3 consecutive, unexplained fetal losses before 10th week
UW. Antiphospholipid. table. clinical. pregnancy morbidity.
> = 3 consecutive, unexplained fetal losses before 10th week
…
> =1 premature births of normal neonates before 35th week due to preeclampsia, eclampsia, or placental insufficienty
> = 1 unexplained fetal losses after 10 week
UW. Antiphospholipid. table. clinical. pregnancy morbidity.
> = 3 consecutive, unexplained fetal losses before 10th week
> = 1 unexplained fetal losses after 10 week
…
> =1 premature births of normal neonates before 35th week due to preeclampsia, eclampsia, or placental insufficiency
UW. Antiphospholipid. table. Labs?3
lupus anticoagulant
anticardiolipin antibody
anti-beta2 glycoprotein antibody I
UW. Antiphospholipid. table. criterion?2
1 clinical + 1 lab. criterion must be met
UW. antiphospholipid.
APS is an autoimmune disorder caused by antiphospholipid antibodies (eg, lupus anticoagulant, anticardiolipin antibody) that create a hypercoagulable state leading to venous and/or arterial thrombosis (eg, transient ischemic attack).
During pregnancy, APS can cause placental vessel thrombosis, which may result in Recurrent pregnancy loss or in other pregnancy complications (eg, preeclampsia, placental insufficiency).
UW. antiphospholipid. Due to the high risk of venous and/or arterial thrombosis, patients require …….
require chronic anticoagulation.
UW. antiphospholipid. antogoagulation in pregnant?
pregnant patients receive low molecular weight heparin.
UW. antiphospholipid. anticoagulation in non-pregnant?
Nonpregnant patients are anticoagulated with warfarin
UW. etiologies for recurrent pregnancy loss.
There are multiple etiologies for RPL, including
structural (eg, uterine anomaly),
genetic (eg, aneuploidy), a
nd endocrine (eg, diabetes mellitus) causes.
However, in this young woman (UW case) who has also had a prior episode of sudden weakness and slurred speech (suggesting a transient ischemic attack), the most likely etiology of her RPL is antiphospholipid antibody syndrome (APS).
UW. Antiphospholipid-antibody syndrome (APS) is ……..? CP?
A prothrombotic autoimmune disorder that can present with recurrent pregnancy losses, arterial or venous thrombosis, and mild thrombocytopenia.
UW. Antiphospholipid-antibody require what?
APS require anticoagulation (eg, low-molecular-weight heparin in pregnant patients) to decrease the risk of complications.
UW. reccurent loss + Submucosal and intracavitary uterine fibroids. how is caused?
Submucosal and intracavitary uterine fibroids may cause RPL due to interference with implantation.
UW. recurrent + Subserosal fibroids???
Subserosal fibroids are located outside the uterine cavity and therefore typically DO NOT interfere with implantation or cause miscarriage.
only submucosal and intracavitary
UW case. 35yo + gravida 4 para 1 aborta 2. previous losses in early first trimester. now menses 7 weeks ago. 6 months ago had episode of slurred speech and sudden right arm weakness, that resolved after 2 days. Now UG empty uterus, hCG 23, closed cervix, no bleeding, uterus slightly enlarged, irregular shaped, ug - 2c, subserosal fibroid. BMI 32.
Cause of patients miscarriage?
Hypercoagulable state
UW. Antiphospholipid-antibody syndrome (APS). Antiphospholipid antibodies disrupt the function of …. and cause…..???
disrupt the function of platelets and vascular endothelial cells to create a hypercoagulable state.
UW. Antiphospholipid-antibody syndrome (APS).
The initial presentation of APS is often an unprovoked arterial or venous thrombosis (eg, stroke, deep venous thrombosis).
What additional presentation in pregnancy?
In pregnant patients with APS, persistent thrombosis of placental vessels causes pregnancy complications or recurrent pregnancy losses, as in this patient
UW. Antiphospholipid-antibody syndrome (APS).
typical thrombotic CP + no labs done yet to confirm. Next step in Mx?
Although additional antibody testing is needed to confirm the diagnosis of APS in this patient, the best next step is to initiate anticoagulation to decrease her risk of thrombosis and pregnancy complications.
In pregnant patients = low-molecular-weight heparin
UW. Antiphospholipid-antibody syndrome (APS).
APS antibodies (3 were mentioned) can cross react with what???????
These antibodies can cross-react with a VDRL test to produce a false-positive result.
In case was positive VDRL.
UW. Antiphospholipid-antibody syndrome (APS). APS antibodies (3 were mentioned) can interfere with what blood components?????
they can also interfere with coagulation test reagents, resulting in an artificially prolonged activated PTT. Mild thrombocytopenia (immune mediated) is typical.
UW. Antiphospholipid-antibody syndrome (APS). what CBC finding is typical?
Mild thrombocytopenia (immune mediated) is typical.
UW. Case: 25y/o. prior 2 pregnancies ended in first-trimester spontaneous abortions. Now 6 weeks gestation. Labs.: plt 98k; ADTL 46s; PT 10s; VDRL - positive; FTA-ABS - negative. UG - 6 weeks fetus. Best next step Mx?
LMWH.
Despite need to do antifosfolipid antibodies to confirm, but give anticoagulation to decr. risk for thrombosis and pregnancy complications. Bet atsakymuose buvo tik medikamentai, varianto kad daryti labs tai nebuvo.